2017
DOI: 10.12688/f1000research.11553.1
|View full text |Cite
|
Sign up to set email alerts
|

From disease modelling to personalised therapy in patients with CEP290 mutations

Abstract: Mutations that give rise to premature termination codons are a common cause of inherited genetic diseases. When transcripts containing these changes are generated, they are usually rapidly removed by the cell through the process of nonsense-mediated decay. Here we discuss observed changes in transcripts of the centrosomal protein CEP290 resulting not from degradation, but from changes in exon usage. We also comment on a landmark paper (Drivas et al. Sci Transl Med. 2015) where modelling this process of exon us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 22 publications
0
11
0
Order By: Relevance
“…While restoration of developmental defects ( e.g ., skeletal anomalies) may only be possible at an early stage of human development, other phenotypic presentations, such as retinal degeneration or kidney function, may have a longer window of opportunity for intervention. Encouragingly, progress towards such therapies is being made: For example, “rescues” of mutations in the CEP290 gene, which encodes a TZ protein, have been demonstrated in a murine ciliopathy model, as well as in patient cells .…”
Section: Discussionmentioning
confidence: 99%
“…While restoration of developmental defects ( e.g ., skeletal anomalies) may only be possible at an early stage of human development, other phenotypic presentations, such as retinal degeneration or kidney function, may have a longer window of opportunity for intervention. Encouragingly, progress towards such therapies is being made: For example, “rescues” of mutations in the CEP290 gene, which encodes a TZ protein, have been demonstrated in a murine ciliopathy model, as well as in patient cells .…”
Section: Discussionmentioning
confidence: 99%
“…There is hope therefore that these and other animal models of NPHP will provide valuable insights for future personalized medicine treatments of NPHP in affected patients ( 162 ). However, despite the great number of promising interventions that has arisen from preclinical studies, no clinical trials have yet been conducted to test their therapeutic potential in NPHP patients, most of whom eligible for treatment would be less than 18 years of age ( 125 ).…”
Section: Treatment Of Nphpmentioning
confidence: 99%
“…In the same terms, PC can also be applied for the calculation of carrier frequencies (CF) [16,19] of causal variants of non-related diseases in genes with a recessive inheritance pattern, as well as in the analysis of trios [18,19]. In more complex scenarios, where modifying and risk/protective variants may tune the effect of causal variants, the mutational landscape of a disease may help identifying: i) genetic pleiotropy together with causal variants in recessive forms [22], ii) digenic inheritance [23], or iii) disease-associated triallelic sites as in BBS [24].…”
Section: Introductionmentioning
confidence: 99%